Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
IDR 1390
Key Takeaways
Risk factor
Resilient to price shocks
Data is available to registered users only
Data is available to registered users only
Profitability factor
Overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
PT Medikaloka Hermina Tbk operates a network of general hospitals in Indonesia. As of December 31, 2021, the company operated 43 hospitals with 5,877 beds. It is also involved in the investment and education service businesses. The company was founded in 1985 and is based in Jakarta, Indonesia.
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBITD.
Data is available to registered users only
Target Price
The average target price of HEAL.JK is 1615 and suggests 16% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Data is available to registered users only
Buy
Sell